GS
LKFT

GTS Securities’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

GTS Securities’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,563
Closed -$348K – 4080
2023
Q4 		$348K Buy
+8,563
New +$315K ﹤0.01% 3086

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GTS Securities's LKFT Position: Q1 2024 in Review

GTS Securities sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 8,563 shares — an estimated $348K sold.

GTS Securities first reported a position in LKFT in Q4 2023 and held it in 1 quarter. The position peaked at $348K in Q4 2023. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

  • GTS Securities reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • GTS Securities sold 8,563 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $348K.
  • GTS Securities first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2023 and held it in 1 quarter.
  • GTS Securities's Lakefront Biotherapeutics American Depositary Shares position peaked at $348K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.